SMTL ID : 5w84.2 (1 other biounit)

CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x 9YY: 4-(benzylamino)-6-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]pyridine-3-carboxamide(Non-covalent)

9YY.1: 15 residues within 4Å: Chain A: M.37, G.38, E.39, G.40, V.45, A.56, V.91, Y.107, V.108, Y.109, M.110, G.113, L.163, S.173, D.174 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.45, A:V.91, A:V.91, A:Y.107, A:L.163 Hydrogen bonds: A:Y.107, A:V.108, A:M.110, A:M.110, A:G.113 pi-Stacking: A:Y.107, A:Y.107

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bhide, R.S. et al., Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-10-11

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence